Latest Stories

Don’t miss our hot and upcoming stories
Will GSK’s Fluviral Supply Strengthen Canada’s Seasonal Flu Preparedness?

Key Highlights Public Health ImpactAnnual flu vaccination remains the most effective tool to reduce flu-related…

ByByAnuja Singh Sep 8, 2025
Could Takeda’s Landmark Phase 3 Oveporexton Results Redefine the Standard of Care in Narcolepsy Type 1?

Key Highlights Clinical Breakthroughs Across EndpointsPatients treated with oveporexton demonstrated marked improvements in excessive daytime…

ByByAnuja Singh Sep 8, 2025
Could Roche’s New Vabysmo Data Redefine Long-Term Care in “wet” age-related macular degeneration (nAMD)?

Key Highlights Durability Demonstrated in AVONELLE-XRoche presented four-year data from AVONELLE-X at the Euretina 2025…

ByByAnuja Singh Sep 7, 2025
Is Abbott’s Dissolving Stent Set to Transform Peripheral Artery Disease Treatment in Europe?

Key Highlights A Breakthrough in PAD TreatmentAbbott has received CE Mark approval in Europe for…

ByByAnuja Singh Sep 7, 2025
Scroll to Top